Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies is a research paper published in Cytotherapy (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: ZIA BC 011823
National Institutes of Health
Grant: K08CA267057
Cancer Moonshot
Grant: 3U54CA232568-01S4
European Hematology Association
Hyundai Hope On Wheels
Clinical Center
Stichting Lymph&Co
FWCI
0.46
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords